[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fTIjt6MEhJOvtj18ZFF2l_LycqrNLO5ZfrRSfiWUOBWA":8,"$fDo-bLBXGYrljBaZ7G7vvoJhDYP-m4Tf4jZm2PeIOwug":56,"$fspTLZGhh4zqxwqG1MLVho8WpIfAR-OBYEPQJg0IvefI":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},31084,868522,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","董廷廷","蒙城县第二人民医院","普外科","住院医师",24,0,"胆管癌早期信号与治疗指南，一定要知道！","","https://ystcdn.venuertc.com/venue/AI/adb97ecd-3e77-4bd9-a035-0c30926e81b7.jpg","\u003Cdiv class=\"material-cholangiocarcinoma-wrapper\">   \u003Ch1 id=\"material_title\" class=\"material-cholangiocarcinoma-title\">胆管癌全面了解：诊断、分期与治疗指南\u003C/h1>    \u003Cdiv class=\"material-cholangiocarcinoma-section material-cholangiocarcinoma-bg1\">     \u003Ch2 class=\"material-cholangiocarcinoma-subtitle\">01 容易被忽视的早期信号 🕵️‍♂️\u003C/h2>     \u003Cdiv class=\"material-cholangiocarcinoma-content\">       \u003Cp>         日常生活中，如果你曾短暂地感觉皮肤发黄或食欲略微下降，可能并没有放在心上。然而，这些轻微、偶尔出现的小变化有时与胆管癌相关，尤其在疾病初期，非常容易被忽略。大多数人只在身体持续不适时才会选择就医，但早期定期体检，却能让很多大问题无声无息地化解。       \u003C/p>       \u003Cp>         胆管癌的早期，身体里的“异常细胞”动作很隐蔽，有些类似管道刚刚出现细微堵塞，表面上毫无波澜。比如，偶发的消化不良、轻度乏力或者黄疸只是短暂出现，很快又自行缓解。       \u003C/p>       \u003Cdiv class=\"material-cholangiocarcinoma-tip\">         \u003Cspan>TIP：\u003C/span>如果最近感到饭量变小但没明显原因、肤色偶尔变黄，或者偶尔发痒、容易疲劳，这些都最好记得和医生聊一聊，并不是每一次不适都要紧张，但小心观察能助早发现。       \u003C/div>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-cholangiocarcinoma-section material-cholangiocarcinoma-bg2\">     \u003Ch2 class=\"material-cholangiocarcinoma-subtitle\">02 这些表现要当心 ⚠️\u003C/h2>     \u003Cdiv class=\"material-cholangiocarcinoma-content\">       \u003Cul class=\"material-cholangiocarcinoma-list\">         \u003Cli>           \u003Cstrong>皮肤/眼白明显发黄：\u003C/strong>持续的黄疸是胆管癌典型信号之一。有位52岁的男性，发现自己近一个月眼白一直泛黄，才想到去医院，最后被确诊为肝外胆管癌。这个例子提醒我们，不要一味以为“火气大”就能解释皮肤发黄，出现持续变色应尽快检查。         \u003C/li>         \u003Cli>           \u003Cstrong>持续腹部胀痛：\u003C/strong>有些人肚子隐浅胀痛，后来腹胀越来越频繁且剧烈。胆管狭窄或者堵塞，胆汁流不畅，容易带来腹部疼痛感。这种腹痛通常位置固定、并呈现加重趋势。         \u003C/li>         \u003Cli>           \u003Cstrong>体重持续下降：\u003C/strong>和饮食无关的明显变瘦，是身体“亮红灯”的信号。比如平常饭量没变，但两三个月体重肉眼可见下滑，别总以为是运动多了或减肥成功，这种快速消瘦要及时医查。         \u003C/li>       \u003C/ul>       \u003Ctable class=\"material-cholangiocarcinoma-table\">         \u003Cthead>           \u003Ctr>             \u003Cth>症状\u003C/th>             \u003Cth>表现方式\u003C/th>           \u003C/tr>         \u003C/thead>         \u003Ctbody>           \u003Ctr>             \u003Ctd>黄疸\u003C/td>             \u003Ctd>皮肤/眼白发黄，并持续存在\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>腹部疼痛\u003C/td>             \u003Ctd>固定部位、逐渐加重\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>体重减轻\u003C/td>             \u003Ctd>短时间明显减少，无特殊原因\u003C/td>           \u003C/tr>         \u003C/tbody>       \u003C/table>       \u003Cdiv class=\"material-cholangiocarcinoma-tip\">         \u003Cspan>小贴士：\u003C/span>持续症状≥2周不要拖延，长时间异常常有深层原因。       \u003C/div>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-cholangiocarcinoma-section material-cholangiocarcinoma-bg3\">     \u003Ch2 class=\"material-cholangiocarcinoma-subtitle\">03 哪些因素会增加风险？🔬\u003C/h2>     \u003Cdiv class=\"material-cholangiocarcinoma-content\">       \u003Cp>         胆管癌产生与多种影响有关，尤其与胆管长期损伤和反复刺激密切。       \u003C/p>       \u003Cul>         \u003Cli>           \u003Cstrong>慢性胆管疾病：\u003C/strong>比如长期胆管结石、胆管炎症反复发作时，会让管道壁受到长期摩擦，这些慢性炎症累积，增加了细胞异常生长的风险。         \u003C/li>         \u003Cli>           \u003Cstrong>慢性肝病：\u003C/strong>如乙肝、丙肝等肝炎患者，肝脏长期损害，影响胆道功能，容易让胆管癌“趁虚而入”。         \u003C/li>         \u003Cli>           \u003Cstrong>年龄与遗传：\u003C/strong>年龄越大，细胞修复能力下降。医学上观察到，胆管癌患者多见于50岁后，家族中若有类似肿瘤的成员也不可大意。         \u003C/li>         \u003Cli>           \u003Cstrong>其他病因：\u003C/strong>如某些先天异常（如胆囊囊肿）、胆道畸形也会增加患癌风险。         \u003C/li>       \u003C/ul>       \u003Cdiv class=\"material-cholangiocarcinoma-table-wrapper\">         \u003Ctable class=\"material-cholangiocarcinoma-table\">           \u003Ctr>             \u003Cth>主要风险因素\u003C/th>             \u003Cth>相关机制\u003C/th>           \u003C/tr>           \u003Ctr>             \u003Ctd>胆管结石/慢性炎症\u003C/td>             \u003Ctd>长期损伤胆管细胞，增加变异概率\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>慢性肝病\u003C/td>             \u003Ctd>肝脏影响胆汁代谢，使胆管长期暴露在有害物质中\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>遗传/家族史\u003C/td>             \u003Ctd>特定基因变异，易感性较高\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>年龄偏大\u003C/td>             \u003Ctd>细胞修复功能下降，突变几率增加\u003C/td>           \u003C/tr>         \u003C/table>       \u003C/div>       \u003Cdiv class=\"material-cholangiocarcinoma-tip\">         \u003Cspan>友情提示：\u003C/span>高危人群并不等于一定发病，但更要重视身体变化。       \u003C/div>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-cholangiocarcinoma-section material-cholangiocarcinoma-bg4\">     \u003Ch2 class=\"material-cholangiocarcinoma-subtitle\">04 科学防控这样做 🥗\u003C/h2>     \u003Cdiv class=\"material-cholangiocarcinoma-content\">       \u003Cp>         积极的健康管理，尤其适用于有慢性肝病、胆管结石、50岁以上和家族有相关病例的人群。日常生活小细节能帮我们很大忙，关键在于做到“主动发现，及时应对”。       \u003C/p>       \u003Cdiv class=\"material-cholangiocarcinoma-table-wrapper\">         \u003Ctable class=\"material-cholangiocarcinoma-table\">           \u003Ctr>             \u003Cth>推荐食物\u003C/th>             \u003Cth>有益功效\u003C/th>             \u003Cth>食用建议\u003C/th>           \u003C/tr>           \u003Ctr>             \u003Ctd>深色蔬菜（如紫甘蓝、西兰花）\u003C/td>             \u003Ctd>丰富抗氧化物，帮助细胞修复\u003C/td>             \u003Ctd>每餐都适量搭配，有助身体平衡\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>粗粮\u003C/td>             \u003Ctd>增加膳食纤维，促进胆汁代谢\u003C/td>             \u003Ctd>可替代部分细白米面，搭配主食吃\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>优质蛋白（如鱼肉、豆制品）\u003C/td>             \u003Ctd>提高免疫力，维护肝胆功能\u003C/td>             \u003Ctd>每天摄入，避免一成不变\u003C/td>           \u003C/tr>         \u003C/table>       \u003C/div>       \u003Cul>         \u003Cli>定期体检：建议每年基查肝胆B超，有高危因素可与医生沟通是否增加检查频率。\u003C/li>         \u003Cli>注意肝胆健康：如果已有慢性肝炎，积极规范治疗；有胆结石及时处理，减少胆道反复刺激。\u003C/li>         \u003Cli>选择正规医院：发现异常症状尽快到三甲医院消化科或肝胆外科就诊。\u003C/li>       \u003C/ul>       \u003Cdiv class=\"material-cholangiocarcinoma-tip\">         \u003Cspan>健康建议：\u003C/span>饮食多样化才关键，越是单一越不利；关注身体信号，有事宁可多问一嘴。       \u003C/div>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-cholangiocarcinoma-section material-cholangiocarcinoma-bg5\">     \u003Ch2 class=\"material-cholangiocarcinoma-subtitle\">05 诊断方式一览 🔎\u003C/h2>     \u003Cdiv class=\"material-cholangiocarcinoma-content\">       \u003Cp>         胆管癌的检查流程环环相扣。常见方式包括：       \u003C/p>       \u003Cul>         \u003Cli>\u003Cstrong>影像检查：\u003C/strong>如B超、CT、MRI等，查看胆管是否有狭窄、肿块及是否侵犯周围组织。\u003C/li>         \u003Cli>\u003Cstrong>血液指标：\u003C/strong>通过肝功能和肿瘤标志物（如CA19-9）辅助判断异常。\u003C/li>         \u003Cli>\u003Cstrong>病理活检：\u003C/strong>取得可疑部位组织后，在显微镜下确认是否有异常细胞。\u003C/li>       \u003C/ul>       \u003Cp>         这些手段可以帮助医生搞清楚肿瘤类型和发展阶段，从而量身制定下一步治疗计划。每种检查各有侧重，医生会根据实际选择合适的组合。比如影像有时候发现不了特别早期的微小病灶，这时血液指标就能提供线索；而一旦怀疑恶性肿瘤，活检成为决定性一步。       \u003C/p>       \u003Cdiv class=\"material-cholangiocarcinoma-tip\">         \u003Cspan>别忘了：\u003C/span>肝胆影像检查痛苦小、效率高，是最早期识别胆管病变的简单办法。       \u003C/div>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-cholangiocarcinoma-section material-cholangiocarcinoma-bg6\">     \u003Ch2 class=\"material-cholangiocarcinoma-subtitle\">06 分期与治疗全攻略 🩺\u003C/h2>     \u003Cdiv class=\"material-cholangiocarcinoma-content\">       \u003Cp>         胆管癌的分期好比“病情地图”，清晰显示肿瘤发展程度。临床上多采用TNM分期：T（肿瘤原发大小）、N（附近淋巴结情况）、M（有无远处转移），医生会综合评估来定制治疗策略。       \u003C/p>       \u003Ctable class=\"material-cholangiocarcinoma-table\">         \u003Cthead>           \u003Ctr>             \u003Cth>分期\u003C/th>             \u003Cth>特点\u003C/th>             \u003Cth>治疗选择\u003C/th>           \u003C/tr>         \u003C/thead>         \u003Ctbody>           \u003Ctr>             \u003Ctd>早期（I-II期）\u003C/td>             \u003Ctd>肿瘤局限胆管，无远处转移\u003C/td>             \u003Ctd>优先手术切除（如胆管切除、肝部分切除/移植）\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>局部晚期（III期）\u003C/td>             \u003Ctd>肿瘤已侵犯邻近器官或淋巴结\u003C/td>             \u003Ctd>手术+辅助化疗/放疗\u003C/td>           \u003C/tr>           \u003Ctr>             \u003Ctd>晚期（IV期）\u003C/td>             \u003Ctd>存在远处转移\u003C/td>             \u003Ctd>主要为化疗、放疗及靶向治疗\u003C/td>           \u003C/tr>         \u003C/tbody>       \u003C/table>       \u003Cul>         \u003Cli>手术：早期首选，充分切除后部分病例能获得漫长生存期\u003C/li>         \u003Cli>化疗/放疗：多数针对不能手术或已扩散病例，目的是抑制疾病进展\u003C/li>         \u003Cli>靶向治疗：对部分特定分子标记阳性的人群有效，副作用小于传统化疗\u003C/li>       \u003C/ul>       \u003Cdiv class=\"material-cholangiocarcinoma-tip\">         \u003Cspan>友情提醒：\u003C/span>治疗方式需与专业医生详细讨论，每个人的方案都应“量身定制”。       \u003C/div>       \u003Cdiv class=\"material-cholangiocarcinoma-tip material-cholangiocarcinoma-tip-warning\">         \u003Cspan>副反应应对：\u003C/span>治疗期间如遇乏力、恶心等并发症，一定主动告知医生，合理用药及调整生活作息很关键。       \u003C/div>     \u003C/div>   \u003C/div>  \u003C/div>  \u003Cstyle> .material-cholangiocarcinoma-wrapper {   font-family: 'Segoe UI', 'Helvetica Neue', Arial, 'PingFang SC', sans-serif;   max-width: 800px;   margin: 40px auto;   padding: 20px 18px 38px 18px;   background: #fafbfc;   border-radius: 18px;   box-shadow: 0 8px 32px rgba(70, 115, 169, 0.09);   color: #253346; } .material-cholangiocarcinoma-title {   font-size: 2.3em;   color: #214158;   border-left: 10px solid #65b0b8;   padding-left: 12px;   margin-bottom: 36px;   margin-top: 0;   font-weight: 700;   letter-spacing: 0.01em; } .material-cholangiocarcinoma-section {   margin-bottom: 38px;   padding: 30px 24px 22px 24px;   border-radius: 14px;   box-sizing: border-box; } .material-cholangiocarcinoma-bg1 {   background: linear-gradient(90deg, #ebf8fc 0%, #fafdfe 100%); } .material-cholangiocarcinoma-bg2 {   background: linear-gradient(90deg, #f5f7eb 0%, #fcfefa 100%); } .material-cholangiocarcinoma-bg3 {   background: linear-gradient(90deg, #fbeeee 0%, #fff9f9 100%); } .material-cholangiocarcinoma-bg4 {   background: linear-gradient(90deg, #f5f9ee 0%, #fafdfe 100%); } .material-cholangiocarcinoma-bg5 {   background: linear-gradient(90deg, #eef5fa 0%, #fafdfe 100%); } .material-cholangiocarcinoma-bg6 {   background: linear-gradient(90deg, #f4f0f8 0%, #fafdfe 100%); } .material-cholangiocarcinoma-subtitle {   font-size: 1.4em;   margin: 0 0 12px 0;   color: #3d6082;   font-weight: 600;   letter-spacing: 0.01em;   position: relative; } .material-cholangiocarcinoma-content {   font-size: 1.06em;   color: #27344c;   line-height: 1.8; } .material-cholangiocarcinoma-list {   margin: 4px 0 18px 0;   padding-left: 20px; } .material-cholangiocarcinoma-list li {   margin-bottom: 12px;   padding-left: 2px; } .material-cholangiocarcinoma-table-wrapper {   margin: 18px 0 10px 0; } .material-cholangiocarcinoma-table {   width: 100%;   border-collapse: collapse;   font-size: 0.97em;   background: #fff;   border-radius: 6px;   overflow: hidden;   box-shadow: 0 2px 8px #dae2ec33; } .material-cholangiocarcinoma-table th, .material-cholangiocarcinoma-table td {   border: 1px solid #e4ebf1;   padding: 10px 8px;   text-align: left;   background: #fafcfd; } .material-cholangiocarcinoma-table th {   background: #ecf6fe;   color: #266c7e;   font-weight: 600; } .material-cholangiocarcinoma-table tr:nth-child(even) td {   background: #f7fbfe; } .material-cholangiocarcinoma-tip {   background: #e9f4fa;   color: #187a96;   font-size: 1em;   margin-top: 16px;   border-radius: 6px;   padding: 10px 13px;   display: flex;   align-items: center; } .material-cholangiocarcinoma-tip span {   font-weight: bold;   margin-right: 6px; } .material-cholangiocarcinoma-tip-warning {   background: #fff3c5;   color: #ab7208;   border-left: 5px solid #f2ba3c;   margin-top: 10px; } @media (max-width: 790px) {   .material-cholangiocarcinoma-wrapper {     padding: 10px 2vw 28px 2vw;     max-width: 97vw;   }   .material-cholangiocarcinoma-section {     padding: 15px 2vw 13px 2vw;   }   .material-cholangiocarcinoma-title {     font-size: 1.28em;   } } \u003C/style>","全面了解胆管癌的早期信号、风险因素与科学防控方法。关注健康，及时就医，提升生活质量！",558,"2025-05-09 10:32:50","胆管癌早期信号与治疗指南 - 关键症状与最新疗法解析  ","胆管癌早期症状,胆管癌治疗指南,胆管癌信号,胆管癌诊断,胆管癌预防,胆管癌生存率  ","了解胆管癌的早期预警信号（如黄疸、腹痛、体重骤降）及最新治疗手段（手术、化疗、靶向治疗）。本指南提供关键诊疗信息，帮助患者及时识别并科学应对胆管癌，提升生存率。","2025-06-07 14:52:00",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]